- Sector
- Technology services
- Industry
- Data processing services
- Address
- Jeju South Korea
- IPO Date
- Nov 18, 2025
- Business
- iL Robotics Co., Ltd. develops, manufactures, and commercializes precision medical devices, specialized dental equipment, and robotics-assisted healthcare solutions. The company operates across several primary product segments, including dental and surgical micromotor systems, comprising brushless DC (BLDC) electric micromotors, implant surgical motor units, endodontic motor systems, and digital electronic control consoles; dental handpieces and clinical instruments, comprising high-speed optical and non-optical air turbines, low-speed contra-angle and straight handpieces, and cordless dental handpieces; dental laboratory equipment, comprising high-torque micromotors, grinding, cutting, and polishing systems for dental technicians; and medical robotics and intelligent healthcare devices, comprising robotic dental surgical assistance platforms, precision motion control actuators, and automated clinical tools. Additionally, the company provides original equipment manufacturing (OEM), original design manufacturing (ODM), and after-sales maintenance and technical support services. It serves dental hospitals, private clinics, dental laboratories, and medical device distributors across South Korea, North America, Europe, the Asia-Pacific region, and the Middle East.
Founded in 2001 and headquartered in Daegu, South Korea, iL Robotics Co., Ltd. operates as a member of the IL Science Co., Ltd. corporate group and is listed on the Korea Exchange under the ticker KRX:403810. In recent operational and strategic developments, the company executed a corporate restructuring and rebranded from Micro-NX Co., Ltd. to iL Robotics Co., Ltd. following its acquisition by IL Science Co., Ltd., transitioning its core growth strategy toward AI-integrated medical robotics, smart healthcare technologies, and advanced clinical automation. Supported by capital investment and technology synergies from its parent entity, the company has expanded its research and development pipeline for automated surgical robotics, introduced next-generation cordless dental handpiece lines, broadened its international regulatory certifications including CE and FDA compliance, and established strategic clinical research partnerships with dental academic institutions to accelerate global market commercialization.